+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Digital Transformation and Emerging Technology in the Healthcare Industry - 2022 Edition

  • PDF Icon


  • 73 Pages
  • October 2022
  • Region: Global
  • GlobalData
  • ID: 5696565
The pharmaceutical industry is undergoing constant changes resulting from declining profit margins, cost pressure, necessity to replenish pipelines and maximize peak sales, while at the same time meeting stringent regulatory and legislative requirements. Although adoption of innovative technologies was seen as one of the ways to ease these pressures, the COVID-19 pandemic made digitalization of the sector even more pressing. Nevertheless, increasing inflation, fueled by the COVID-19 pandemic and geopolitical events such as the ongoing Ukraine conflict started to challenge digital transformation efforts in the healthcare sector.


In this report, the publisher tracks the progress of digital transformation in the healthcare industry, examines the business preparedness to embrace innovations, and uncovers the current and future technology-related investment trends.


  • Benchmark the level of business readiness and adoption
  • Better understand the business functions impacted the most
  • Assess barriers to adoption
  • Define requirements for success
  • Determine the importance of emerging technologies to healthcare organizations
  • Evaluate levels of investment
  • Assess the impact of COVID-19 on digitalization efforts
  • Explore how inflation is affecting digital transformation progress

Study Design

A total of 114 the publisher's Pharma clients and prospects participated in the 10-minute survey, which was fielded from September 14, 2022, to October 10, 2022.

Components of the report include:

  • Scope of Digital Transformation Strategies - main objectives of digital strategy within the pharmaceutical industry providing respondent mix by region, company size, and respondent seniority
  • COVID-19 Pandemic and Digital Transformation - assesses the impact of COVID-19 on the speed of digital transformation and innovation in pharmaceutical industry
  • Inflation Impact on Digital Transformation - examines how the inflation is impacting digital transformation efforts
  • Challenges to Digital Transformation - highlights key hinderances healthcare organizations face when implementing digital transformation providing respondent mix by region and company size
  • Important Factors for Digital Transformation - determines the key factors required to successfully implement digital transformation providing respondent mix by company size
  • Uptake of Emerging Technologies - examines the key emerging technologies being invested in by healthcare organizations providing respondent mix by region and company size
  • Impact of emerging technologies on pharmaceutical sector - provides the analysis and insights on how technologies are being applied in the healthcare industry and what improvements in business processes these technologies can provide

Reasons to Buy

  • Stay up to date on the scope, challenges, and essentials for the digital transformation within the healthcare industry
  • Explore how innovations are transforming the healthcare industry and what impact on the sector these technologies will have in the near future
  • Develop and design your corporate strategies through an in-house expert analysis of the key factors of digital transformation and emerging technology in the healthcare sector
  • Develop business strategies by understanding the key factors of digital transformation and emerging technology in the healthcare sector
  • Identify emerging industry trends in the uptake of emerging technologies to gain a competitive advantage

Table of Contents

1. Objectives and Design
1.1.1. Respondent Mix
1.1.2. Key Findings
2. Overview of Digital Transformation
2.1.1. Overview of Digital Transformation
2.1.2. COVID-19 Impact of Digital Transformation
3. Digital Transformation Strategies
3.1.1. Digital Transformation Strategies
3.1.2. Clinical Trial Disruptions during COVID-19 Crisis
3.1.3. Addressing Clinical Trial Disruptions
3.1.4. Physician Interactions with Pharma Sales Reps Post-COVID-19
3.1.5. Impact of COVID-19 on Social Media Usage
4. Digital Transformation Objectives
4.1.1. Digital Transformation Objectives - COVID-19
4.1.2. Collaboration Between Pharmaceutical Industry and Tech
4.1.3. Digital Transformation Objectives
4.1.4. Digital Transformation Growth
5. Obstacles to Digital Transformation
6. Concerns Associated with Digital Transformation
6.1.1. Concerns Associated with Digital Transformation
6.1.2. Concerns Associated with Digital Transformation - In Their Words
7. Necessities for Digital Transformation
8. Emerging Technologies - Investment Trends
8.1.1. Emerging Technologies
8.1.2. COVID-19 Impact on Investment in Emerging Technologies
8.1.3. The Future of Robotics in Manufacturing
8.1.4. Disruptive Emerging Technologies
8.1.5. Job Analytic Graphs on AI and Big Data
8.1.6. Disruptive Emerging Technologies - In Their Words
8.1.7. Case Study - AI’s Role in Drug Discovery Process
8.1.8. Case Study - Telehealth Expansion During COVID-19
8.1.9. Case Study - Drug Repurposing and Screening Using AI
8.1.10. Case Study - AI and the Future of Personalized Medicine
8.1.11. Case Study - AI Triumphs in the Fight Against COVID-19
9. Summary of Key Findings
9.1.1. Digital Transformation - In Their Words
9.1.2. Key Findings
10. Appendix
10.1.1. Bibliography
10.1.2. About the Authors
11. Contact the Publisher